The Times Australia
News From Asia

.

Improving global research discoverability and visibility through ScienceDirect

New report highlights how world-leading academic publishers and ScienceDirect are collaborating to help researchers find and access research more easily

AMSTERDAM, NETHERLANDS - News Direct - 24 May 2023 - ScienceDirect, the Elsevier platform that is a leading source of scientific, technical, and medical research, has today published its 'Expanded reach on a trusted platform' report. The report is free to download and explores the initial results of ScienceDirect's pilot initiative that enables researchers to search and discover articles from five publishing partners alongside content from Elsevier journals.

Since January 2022, American Chemical Society (ACS), the Royal Society of Chemistry (RSC), Taylor & Francis, and Wiley have made selected Organic Chemistry and Transportation research articles discoverable on ScienceDirect alongside Elsevier content. IUCr Journals, published by the International Union of Crystallography, joined the initiative in August 2022.

The report includes data on how research included in the pilot has been discovered and consumed, and insights from authors, readers, and librarians on how they perceive the collaboration. Key highlights include:

  • 90% of ScienceDirect users think the pilot is a good idea.
  • 73% of authors are either positive or very positive about their articles being shared in this way (20% are neutral).
  • Individual journals included in the pilot saw increases of up to 18.8% in total reach for their research included in the initiative.
  • Content in the pilot was more discoverable across a broader and more diverse geographic distribution: Pilot content saw 5% more visits from countries outside of North America and Europe (72%) in comparison to Elsevier organic chemistry content (67%).

The pilot will continue and be expanded beyond its initial scope of Organic Chemistry and Transportation content to cover additional research topics. American Society for Microbiology (ASM) and Brill will join the pilot and their research will be included on ScienceDirect in Spring/ Summer 2023, content from 36 journals will be added from both publishers.

Rose L'Huillier, SVP for Researcher Products at Elsevier, said: "While the pilot is still very new, we have produced this report as part of our commitment to keeping the research community updated on our progress. There is a lot more to do and understand, but we are pleased with the initial results. I'm delighted that ASM and Brill have chosen to take part, and we look forward to collaborating with them and our existing partners on how we can further improve global research discoverability and visibility for authors and help save readers' time."

During the pilot, researchers have been able to discover more than 100,000 articles from 38 industry-leading journals from the participating publishers, through search, recommendations and by browsing content. If an article is Open Access, the full text is available immediately in HTML. For all Open Access content and subscription content to which the user is entitled, researchers see a PDF button on ScienceDirect that indicates they have full text access, which takes them to the PDF hosted on the publisher website. Entitled access is determined using GetFTR, a free-to-use solution for platforms like ScienceDirect that enables real-time entitlement checks for any article. More detail is available about the pilot here.

The issuer is solely responsible for the content of this announcement.

About Elsevier

As a global leader in information and analytics, helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.

In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions, and funders.

Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as , , , and support strategic , , and . Researchers and healthcare professionals rely on our 2,700+ digitized journals, including and ; our 43,000+ eBook titles; and our iconic reference works, such as Gray's Anatomy. With the and our external , we work in partnership with diverse stakeholders to advance in science, research and healthcare in developing countries and around the world.

Elsevier is part of , a global provider of information-based analytics and decision tools for professional and business customers.

Times Magazine

Building a Strong Online Presence with Katoomba Web Design

Katoomba web design is more than just creating a website that looks good—it’s about building an online presence that reflects your brand, engages your audience, and drives results. For local businesses in the Blue Mountains, a well-designed website a...

September Sunset Polo

International Polo Tour To Bridge Historic Sport, Life-Changing Philanthropy, and Breath-Taking Beauty On Saturday, September 6th, history will be made as the International Polo Tour (IPT), a sports leader headquartered here in South Florida...

5 Ways Microsoft Fabric Simplifies Your Data Analytics Workflow

In today's data-driven world, businesses are constantly seeking ways to streamline their data analytics processes. The sheer volume and complexity of data can be overwhelming, often leading to bottlenecks and inefficiencies. Enter the innovative da...

7 Questions to Ask Before You Sign IT Support Companies in Sydney

Choosing an IT partner can feel like buying an insurance policy you hope you never need. The right choice keeps your team productive, your data safe, and your budget predictable. The wrong choice shows up as slow tickets, surprise bills, and risky sh...

Choosing the Right Legal Aid Lawyer in Sutherland Shire: Key Considerations

Legal aid services play an essential role in ensuring access to justice for all. For people in the Sutherland Shire who may not have the financial means to pay for private legal assistance, legal aid ensures that everyone has access to representa...

Watercolor vs. Oil vs. Digital: Which Medium Fits Your Pet's Personality?

When it comes to immortalizing your pet’s unique personality in art, choosing the right medium is essential. Each artistic medium, whether watercolor, oil, or digital, has distinct qualities that can bring out the spirit of your furry friend in dif...

The Times Features

NSW has a new fashion sector strategy – but a sustainable industry needs a federally legislated response

The New South Wales government recently announced the launch of the NSW Fashion Sector Strategy, 2025–28[1]. The strategy, developed in partnership with the Australian Fashion ...

From Garden to Gift: Why Roses Make the Perfect Present

Think back to the last time you gave or received flowers. Chances are, roses were part of the bunch, or maybe they were the whole bunch.   Roses tend to leave an impression. Even ...

Do I have insomnia? 5 reasons why you might not

Even a single night of sleep trouble can feel distressing and lonely. You toss and turn, stare at the ceiling, and wonder how you’ll cope tomorrow. No wonder many people star...

Wedding Photography Trends You Need to Know (Before You Regret Your Album)

Your wedding album should be a timeless keepsake, not something you cringe at years later. Trends may come and go, but choosing the right wedding photography approach ensures your ...

Can you say no to your doctor using an AI scribe?

Doctors’ offices were once private. But increasingly, artificial intelligence (AI) scribes (also known as digital scribes) are listening in. These tools can record and trans...

There’s a new vaccine for pneumococcal disease in Australia. Here’s what to know

The Australian government announced last week there’s a new vaccine[1] for pneumococcal disease on the National Immunisation Program for all children. This vaccine replaces pr...